ArticleClinical cancer research : an official journal of the American Association for Cancer Research2015

First-in-human dose study of the novel transforming growth factor-β receptor I kinase inhibitor LY2157299 monohydrate in patients with advanced cancer and glioma.

Jordi Rodon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.